CLINICAL_TRIALS
trial_result
· 2015-09-14
Clinical Trial Update: Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV [Phase 3]
Summary
Phase III trial evaluating the combination of daclatasvir and sofosbuvir for genotype 3 chronic hepatitis C completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2015-09-14